Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks.

Abstract:

BACKGROUND:Niemann-Pick type C1 disease (NPC1) is a rare progressive neurodegenerative disorder caused by mutations in the NPC1 gene. In this lysosomal storage disorder the intracellular transport and sequestration of several lipids like cholesterol is severely impaired, resulting in an accumulation of lipids in late endosomes and lysosomes. The neurological manifestation of the disease is caused by dysfunction and cell death in the central nervous system. Several animal models were used to analyze the impaired pathways. However, the underlying pathogenic mechanisms are still not completely understood and the genetic variability in humans cannot be reflected in these models. Therefore, a human model using patient-specific induced pluripotent stem cells provides a promising approach. METHODS:We reprogrammed human fibroblasts from a NPC1 patient and a healthy control by retroviral transduction with Oct4, Klf4, Sox2 and c-Myc. The obtained human induced pluripotent stem cells (hiPSCs) were characterized by immunocytochemical analyses. Neural progenitor cells were generated and patch clamp recordings were performed for a functional analysis of derived neuronal cells. Filipin stainings and the Amplex Red assay were used to demonstrate and quantify cholesterol accumulation. RESULTS:The hiPSCs expressed different stem cell markers, e.g. Nanog, Tra-1-81 and SSEA4. Using the embryoid body assay, the cells were differentiated in cells of all three germ layers and induced teratoma in immunodeficient mice, demonstrating their pluripotency. In addition, neural progenitor cells were derived and differentiated into functional neuronal cells. Patch clamp recordings revealed voltage dependent channels, spontaneous action potentials and postsynaptic currents. The accumulation of cholesterol in different tissues is the main hallmark of NPC1. In this study we found an accumulation of cholesterol in fibroblasts of a NPC1 patient, derived hiPSCs, and neural progenitor cells, but not in cells derived from fibroblasts of a healthy individual. These findings were quantified by the Amplex Red assay, demonstrating a significantly elevated cholesterol level in cells derived from fibroblasts of a NPC1 patient. CONCLUSIONS:We generated a neuronal model based on induced pluripotent stem cells derived from patient fibroblasts, providing a human in vitro model to study the pathogenic mechanisms of NPC1 disease.

journal_name

Orphanet J Rare Dis

authors

Trilck M,Hübner R,Seibler P,Klein C,Rolfs A,Frech MJ

doi

10.1186/1750-1172-8-144

subject

Has Abstract

pub_date

2013-09-18 00:00:00

pages

144

issn

1750-1172

pii

1750-1172-8-144

journal_volume

8

pub_type

杂志文章
  • The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015.

    abstract:BACKGROUND:The burden of rare diseases on society and patients' families has increased in Korea. However, because of the infrequency of rare diseases, there is a lack of resources and information to address these cases and inadequate funding for the management of these patients. We investigated the average annual cumul...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1032-6

    authors: Lim SS,Lee W,Kim YK,Kim J,Park JH,Park BR,Yoon JH

    更新日期:2019-02-18 00:00:00

  • Anophthalmia and microphthalmia.

    abstract::Anophthalmia and microphthalmia describe, respectively, the absence of an eye and the presence of a small eye within the orbit. The combined birth prevalence of these conditions is up to 30 per 100,000 population, with microphthalmia reported in up to 11% of blind children. High-resolution cranial imaging, post-mortem...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-2-47

    authors: Verma AS,Fitzpatrick DR

    更新日期:2007-11-26 00:00:00

  • Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

    abstract::Since its enactment in 2000, the European Orphan Medicinal Products Regulation has allowed the review and approval of approaching 70 treatments for some 55 different conditions in Europe. Success does not come without a price, however. Many of these so-called "orphan drugs" have higher price points than treatments for...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-7-74

    authors: Hughes-Wilson W,Palma A,Schuurman A,Simoens S

    更新日期:2012-09-26 00:00:00

  • A quality improvement program to reduce the time on the lung transplant waiting list at the Nantes University Hospital.

    abstract:BACKGROUND:In 2010, the time on the lung transplant waiting list in Nantes University Hospital (NUH) was 9.2 months, compared to a French national median of about 4 months. The NUH transplant unit performs both heart and lung transplantations, which can be seen as competing activities. To fix the problem, the adult Cys...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-017-0748-4

    authors: Danner-Boucher I,Loppinet V,Boxus A,Dary C,Lambert AB,Prieur M,Vallet C,Tissot A

    更新日期:2018-02-08 00:00:00

  • Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.

    abstract::Taliglucerase alfa is an enzyme replacement therapy (ERT) approved for treatment of adult and paediatric patients with Type 1 Gaucher disease (GD) in several countries and the first plant cell-expressed recombinant therapeutic protein approved by the US Food and Drug Administration for humans. Here, we review the find...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-018-0776-8

    authors: Zimran A,Wajnrajch M,Hernandez B,Pastores GM

    更新日期:2018-02-23 00:00:00

  • Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.

    abstract:BACKGROUND:A pattern of major and minor congenital anomalies, facial dysmorphic features, and neurodevelopmental difficulties, including cognitive and social impairments has been reported in some children exposed to sodium valproate (VPA) during pregnancy. Recognition of the increased risks of in utero exposure to VPA ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1064-y

    authors: Clayton-Smith J,Bromley R,Dean J,Journel H,Odent S,Wood A,Williams J,Cuthbert V,Hackett L,Aslam N,Malm H,James G,Westbom L,Day R,Ladusans E,Jackson A,Bruce I,Walker R,Sidhu S,Dyer C,Ashworth J,Hindley D,Diaz G

    更新日期:2019-07-19 00:00:00

  • Anorectal malformations.

    abstract::Anorectal malformations comprise a wide spectrum of diseases, which can affect boys and girls, and involve the distal anus and rectum as well as the urinary and genital tracts. They occur in approximately 1 in 5000 live births. Defects range from the very minor and easily treated with an excellent functional prognosis...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-2-33

    authors: Levitt MA,Peña A

    更新日期:2007-07-26 00:00:00

  • The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?

    abstract:BACKGROUND:It is unknown whether the neonatal tetrahydrobiopterin (BH4) loading test is adequate to diagnose long-term BH4 responsiveness in PKU. Therefore we compared the predictive value of the neonatal (test I) versus the 48-h BH4 loading test (test II) and long-term BH4 responsiveness. METHODS:Data on test I (>199...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0394-2

    authors: Anjema K,Hofstede FC,Bosch AM,Rubio-Gozalbo ME,de Vries MC,Boelen CC,van Rijn M,van Spronsen FJ

    更新日期:2016-01-29 00:00:00

  • Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.

    abstract::The Neuronal Ceroid Lipofuscinoses (NCLs) are a family of autosomal recessive neurodegenerative disorders that annually affect 1:100,000 live births worldwide. This family of diseases results from mutations in one of 14 different genes that share common clinical and pathological etiologies. Clinically, the diseases ar...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0414-2

    authors: Geraets RD,Koh Sy,Hastings ML,Kielian T,Pearce DA,Weimer JM

    更新日期:2016-04-16 00:00:00

  • Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

    abstract:BACKGROUND:Alpha-1 antitrypsin deficiency (AATD) is a rare hereditary condition that leads to decreased circulating alpha-1 antitrypsin (AAT) levels, significantly increasing the risk of serious lung and/or liver disease in children and adults, in which some aspects remain unresolved. METHODS:In this review, we summar...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-018-0856-9

    authors: Torres-Durán M,Lopez-Campos JL,Barrecheguren M,Miravitlles M,Martinez-Delgado B,Castillo S,Escribano A,Baloira A,Navarro-Garcia MM,Pellicer D,Bañuls L,Magallón M,Casas F,Dasí F

    更新日期:2018-07-11 00:00:00

  • The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study.

    abstract:BACKGROUND:X-linked hypophosphataemia (XLH) is a rare, hereditary, progressive and lifelong phosphate wasting disorder characterised by pathological elevations in fibroblast growth factor (FGF) 23 concentration and activity; XLH has an incidence of approximately 1 in 20-25,000 individuals. Excess FGF23 activity leads t...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01434-4

    authors: Padidela R,Nilsson O,Makitie O,Beck-Nielsen S,Ariceta G,Schnabel D,Brandi ML,Boot A,Levtchenko E,Smyth M,Jandhyala R,Mughal Z

    更新日期:2020-06-30 00:00:00

  • Rare diseases and orphan drugs: 500 years ago.

    abstract::In 1581 Rembert Dodoens wrote "Medicinalium observationum exempla rara, recognita et aucta" a Latin book about the diagnosis and treatment of disorders with a low prevalence. ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 传,历史文章,信件

    doi:10.1186/s13023-015-0353-3

    authors: Dooms MM

    更新日期:2015-12-21 00:00:00

  • Behçet's disease.

    abstract:UNLABELLED:DEFINITION OF THE DISEASE: Behçet disease (BD) is a chronic, relapsing, multisystemic disorder characterized by mucocutaneous, ocular, vascular and central nervous system manifestations. EPIDEMIOLOGY:BD seems to cluster along the ancient Silk Road, which extends from eastern Asia to the Mediterranean basin....

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-7-20

    authors: Saadoun D,Wechsler B

    更新日期:2012-04-12 00:00:00

  • Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature.

    abstract:BACKGROUND:Lysosomal storage disorders (LSD) are a rare cause of non immunological hydrops fetalis (NIHF) and congenital ascites. The reported incidence is about 1%. The incidence of idiopathic NIHF is estimated to be about 18%. PATIENTS AND METHODS:We report four cases with transient hydrops fetalis resulting from LS...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-7-86

    authors: Whybra C,Mengel E,Russo A,Bahlmann F,Kampmann C,Beck M,Eich E,Mildenberger E

    更新日期:2012-11-08 00:00:00

  • Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia.

    abstract:BACKGROUND:Classic galactosemia is a rare genetic metabolic disease with an unmet treatment need. Current standard of care fails to prevent chronically-debilitating brain and gonadal complications. Many mutations in the GALT gene responsible for classic galactosemia have been described to give rise to variants with con...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-018-0954-8

    authors: Haskovic M,Derks B,van der Ploeg L,Trommelen J,Nyakayiru J,van Loon LJC,Mackinnon S,Yue WW,Peake RWA,Zha L,Demirbas D,Qi W,Huang X,Berry GT,Achten J,Bierau J,Rubio-Gozalbo ME,Coelho AI

    更新日期:2018-11-26 00:00:00

  • Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.

    abstract:UNLABELLED:Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genodermatosis with severe blistering. No curative treatment is available. Scientific data indicated that epigallocatechin-3-gallate (EGCG), a green tea extract, might improve the phenotype of RDEB patients. In a multicentre, randomized, crossover, ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 信件,随机对照试验

    doi:10.1186/s13023-016-0411-5

    authors: Chiaverini C,Roger C,Fontas E,Bourrat E,Bourdon-Lanoy E,Labrèze C,Mazereeuw J,Vabres P,Bodemer C,Lacour JP

    更新日期:2016-03-25 00:00:00

  • Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation.

    abstract:BACKGROUND:Phenylketonuria (PKU; OMIM#261600) is a rare metabolic disorder caused by mutations in the phenylalanine hydroxylase (PAH) gene resulting in high phenylalanine (Phe) in blood and brain. If not treated early this results in intellectual disability, behavioral and psychiatric problems, microcephaly, motor defi...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-1329-5

    authors: Cannet C,Pilotto A,Rocha JC,Schäfer H,Spraul M,Berg D,Nawroth P,Kasperk C,Gramer G,Haas D,Piel D,Kölker S,Hoffmann G,Freisinger P,Trefz F

    更新日期:2020-02-27 00:00:00

  • Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).

    abstract:BACKGROUND:LCHADD is a long-fatty acid oxidation disorder with immediate symptoms and long-term complications. We evaluated data on clinical status, biochemical parameters, therapeutic regimens and outcome of Austrian LCHADD patients. STUDY DESIGN:Clinical and outcome data including history, diagnosis, short- and long...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-015-0236-7

    authors: Karall D,Brunner-Krainz M,Kogelnig K,Konstantopoulou V,Maier EM,Möslinger D,Plecko B,Sperl W,Volkmar B,Scholl-Bürgi S

    更新日期:2015-02-22 00:00:00

  • Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics.

    abstract:BACKGROUND:The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS:A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierra...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01433-5

    authors: Gómez-Acebo I,Prado SR,De La Mora Á,Puente RZ,de la Roza Varela B,Dierssen-Sotos T,Llorca J

    更新日期:2020-06-29 00:00:00

  • Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease.

    abstract:BACKGROUND:Mucopolysaccharidosis type I (MPS I) is a debilitating hereditary disease characterized by alpha-L-iduronidase (IDUA) deficiency and consequent inability to degrade glycosaminoglycans. The pathological accumulation of glycosaminoglycans systemically results in severe mental retardation and multiple organ dys...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-017-0649-6

    authors: Hsu YH,Liu RS,Lin WL,Yuh YS,Lin SP,Wong TT

    更新日期:2017-06-08 00:00:00

  • Clinical manifestations in female carriers of mucopolysaccharidosis type II: a Spanish cross-sectional study.

    abstract:BACKGROUND:Mucopolysaccharidosis type II (MPS II) is an inherited X-linked disease associated with a deficiency in the enzyme iduronate 2-sulfatase due to iduronate 2-sulfatase gene (IDS) mutations. Recent studies in MPS II carriers did not find clinical involvement, but these were mainly performed by anamnesis and pat...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-92

    authors: Guillén-Navarro E,Domingo-Jiménez MR,Alcalde-Martín C,Cancho-Candela R,Couce ML,Galán-Gómez E,Alonso-Luengo O

    更新日期:2013-06-25 00:00:00

  • The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life.

    abstract:BACKGROUND:Hunter syndrome (mucopolysaccharidosis type II (MPS II)) is a rare metabolic disease that can severely compromise health, well-being and life expectancy. Little evidence has been published on the impact of MPS II on health-related quality of life (HRQL). The objective of this study was to describe this impac...

    journal_title:Orphanet journal of rare diseases

    pub_type: 临床试验,杂志文章

    doi:10.1186/1750-1172-8-101

    authors: Raluy-Callado M,Chen WH,Whiteman DA,Fang J,Wiklund I

    更新日期:2013-07-10 00:00:00

  • Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".

    abstract:BACKGROUND:IgG replacement therapy (IgRT) in primary immunodeficiencies (PID) is a lifelong treatment which may be administered intravenously (IVIg) or subcutaneously (SCIg), at hospital or at home. The objective of the VISAGE study was to investigate if route and/or place for IgRT impact patients' satisfaction regardi...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0452-9

    authors: Bienvenu B,Cozon G,Hoarau C,Pasquet M,Cherin P,Clerson P,Hachulla E,Crave JC,Delain JC,Jaussaud R

    更新日期:2016-06-22 00:00:00

  • The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy.

    abstract:BACKGROUND:The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A. RESULTS:In three individuals with developmental delay w...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-019-1020-x

    authors: Hebebrand M,Hüffmeier U,Trollmann R,Hehr U,Uebe S,Ekici AB,Kraus C,Krumbiegel M,Reis A,Thiel CT,Popp B

    更新日期:2019-02-11 00:00:00

  • The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community.

    abstract::The European Union Committee of Experts on Rare Diseases was entrusted with aiding the European Commission in a number of tasks, ranging from the monitoring of initiatives, to recommending improvements and actions to be pursued in the future, in addition to helping strengthen liaison at both European and International...

    journal_title:Orphanet journal of rare diseases

    pub_type: 社论

    doi:10.1186/1750-1172-9-30

    authors: Aymé S,Rodwell C

    更新日期:2014-02-28 00:00:00

  • New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort.

    abstract:BACKGROUND:Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of alveolar hemorrhage in children and its pathophysiology remains obscure. Classically, diagnosis is based on a triad including hemoptysis, diffuse parenchymal infiltrates on chest X-rays, and iron-deficiency anemia. We present the French pediatric co...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-161

    authors: Taytard J,Nathan N,de Blic J,Fayon M,Epaud R,Deschildre A,Troussier F,Lubrano M,Chiron R,Reix P,Cros P,Mahloul M,Michon D,Clement A,Corvol H,French RespiRare® group.

    更新日期:2013-10-14 00:00:00

  • Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma.

    abstract:OBJECTIVE:NUT midline carcinoma (NMC), a rare type of squamous cell carcinoma, is genetically characterised by NUT midline carcinoma family member 1 (NUTM1) gene rearrangement. NMC can arise from the lungs; however, there is no standard for the management of primary pulmonary NMC. This study aimed to confirm the clinic...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01449-x

    authors: Xie XH,Wang LQ,Qin YY,Lin XQ,Xie ZH,Liu M,Zhang JX,Ouyang M,Liu J,Gu YY,Li SY,Zhou CZ

    更新日期:2020-07-10 00:00:00

  • The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

    abstract::The hyper-IgE syndromes are rare, complex primary immunodeficiencies characterized by clinical manifestation diversity, by particular susceptibility to staphylococcal and mycotic infections as well as by a heterogeneous genetic origin. Two distinct entities--the classical hyper-IgE syndrome which is inherited in an au...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-6-76

    authors: Szczawinska-Poplonyk A,Kycler Z,Pietrucha B,Heropolitanska-Pliszka E,Breborowicz A,Gerreth K

    更新日期:2011-11-15 00:00:00

  • Congenital cataract, facial dysmorphism and demyelinating neuropathy (CCFDN) in 10 Czech Gypsy children--frequent and underestimated cause of disability among Czech Gypsies.

    abstract:BACKGROUND:Congenital Cataract Facial Dysmorphism and demyelinating Neuropathy (CCFDN, OMIM 604468) is an autosomal recessive multi-system disorder which was first described in Bulgarian Gypsies in 1999. It is caused by the homozygous founder mutation c.863 + 389C > T in the CTDP1 gene. The syndrome has been described ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-9-46

    authors: Lassuthova P,Sišková D,Haberlová J,Sakmaryová I,Filouš A,Seeman P

    更新日期:2014-04-01 00:00:00

  • Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation.

    abstract:BACKGROUND:The vision loss in Leber hereditary optic neuropathy patients is due to mitochondrial DNA mutations. No treatment has shown a clear-cut benefit on a clinically meaningful end-point. However, clinical evidences suggest two therapeutic approaches: the reduction of the mutation load in heteroplasmic patients or...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1128-z

    authors: Emperador S,López-Gallardo E,Hernández-Ainsa C,Habbane M,Montoya J,Bayona-Bafaluy MP,Ruiz-Pesini E

    更新日期:2019-06-21 00:00:00